Biomarker validity in the critically ill: all must face the (continuous) renal replacement challenge!

Eitemau Tebyg

• ‘Biomarking’ infection during continuous renal replacement therapy: still relevant?
  gan: Honore, Patrick M, et al.
  Cyhoeddwyd: (2015)
• Presepsin and sepsis-induced acute kidney injury treated with continuous renal replacement therapy: will another promising biomarker bite the dust?
  gan: Honore, Patrick M., et al.
  Cyhoeddwyd: (2015)
• Higher colistin dose during continuous renal replacement therapy: look before leaping!
  gan: Honore, Patrick M., et al.
  Cyhoeddwyd: (2015)
• Continuous renal replacement therapy for safe and adequate voriconazole intravenous treatment: enough reason to be confident?
  gan: Honore, Patrick M, et al.
  Cyhoeddwyd: (2015)
• Is neutrophil gelatinase-associated lipocalin unaffected by convective continuous renal replacement therapy? Definitely … maybe
  gan: Honore, Patrick M., et al.
  Cyhoeddwyd: (2015)